Caleres Q2 2025 slides: Sales and margins decline as tariffs impact performance

Caleres Inc. (NYSE:CAL) shares plunged over 16% in pre-market trading following its Q2 2025 presentation, which revealed a significant and multi-year deterioration in financial performance. The footwear company reported Q2 sales down 3.6% to $659 million and adjusted EPS sharply reduced to $0.35 from $0.85 year-over-year, alongside notable contractions in operating and gross margins, primarily due to tariffs and weakening consumer demand. Despite strategic efforts like the Stuart Weitzman acquisition and $15 million in annualized cost savings, investors reacted negatively, signaling deep concern over Caleres' capacity to reverse persistent sales and profitability declines amid a challenging retail environment and a cautious H2 2025 outlook.

Analysis

Caleres Inc. is experiencing a significant and accelerating deterioration in its financial performance, as evidenced by its Q2 2025 results. The 16.59% pre-market stock plunge to $12.47 reflects deep investor concern over a 3.6% year-over-year revenue decline to $659 million and a sharp drop in adjusted EPS to $0.35, down from $0.85 in the prior-year quarter. This negative trend is systemic, with adjusted operating margin contracting severely to 2.4% from 6.2% and gross margin falling 210 basis points, compounded by a 5% increase in inventory despite falling sales. Both the Brand Portfolio and Famous Footwear segments reported sales declines of 3.5% and 4.9% respectively, with tariff impacts and a 3.4% drop in comparable store sales at Famous Footwear being key detractors. While management highlights strategic initiatives such as the Stuart Weitzman acquisition and $15 million in cost savings, these actions have failed to offset the headwinds from weakening consumer demand and trade policy. The company's cautious outlook, which projects further margin declines in Q3 and the need for external consultants to find more cost savings, suggests that a turnaround is not imminent and operational pressures will persist through the second half of 2025.

Key Decisions for Investors

• Given the accelerating decline in sales and profitability across both major segments, alongside a 16% pre-market share price collapse, investors should view the stock with significant caution and reconsider long positions.
• Monitor Q3 results for any stabilization in Brand Portfolio gross margins and Famous Footwear comparable sales, as management's own cautious guidance indicates these key metrics will likely continue to decline before any potential stabilization in Q4.
• Despite the stock price approaching its 52-week low, the combination of rising inventory against falling sales and severe margin compression suggests a significant risk that Caleres is a value trap rather than a deep value opportunity.
• Closely scrutinize the performance and integration of the newly acquired Stuart Weitzman brand, as its ability to contribute positively is critical but could be hampered by the broader operational and financial challenges facing the company.